Loading
Gestational Diabetes Research and Management / Maternal and Fetal Healthcare · Review
Jurnal Ragam Pengabdian · August 17, 2026
A consensus or society position rather than new primary data.
This systematic review identified nine consistent determinants of hypertensive disorders in pregnancy: chronic hypertension, previous pre-eclampsia, high BMI/obesity, diabetes, kidney disease, nulliparity, advanced maternal age, multiple gestation, and delayed/limited antenatal risk identification. The evidence is organized to support integrated antenatal screening combining biomedical history, obstetric risk, nutrition, environmental context, and access to care, rather than to establish efficacy of any single intervention.
Systematic review following PRISMA 2020 guidance. Pregnant women with exposure to socio-demographic, clinical-metabolic, pregnancy-placental, behavioral-environmental, or health-system determinants of hypertensive disorders in pregnancy.. n = 26.
From 1,114 records searched across PubMed (n=386), Scopus (n=284), ScienceDirect (n=216), Google Scholar (n=220), and public-health sources (n=8), 26 sources met eligibility criteria Most consistent determinants were chronic hypertension, previous pre-eclampsia, high body mass index or obesity, diabetes, kidney disease, nulliparity, advanced maternal age, multiple gestation, and delayed or limited antenatal risk identification Review prioritized articles published mainly from 2022 to 2026 with key official documents retained for epidemiological and guideline context
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should use this synthesis of consistent determinants to structure antenatal risk screening for hypertensive disorders, integrating biomedical and obstetric history with modifiable factors such as BMI, nutrition, and access to care. The review supports a multifactorial approach but does not evaluate specific screening tools or intervention efficacy.
Systematic review synthesizing determinants of hypertensive disorders in pregnancy to support antenatal risk screening, following PRISMA guidance with quality appraisal, but presenting organizational evidence without testing interventions or outcomes.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should use this synthesis of consistent determinants to structure antenatal risk screening for hypertensive disorders, integrating biomedical and obstetric history with modifiable factors such as BMI, nutrition, and access to care. The review supports a multifactorial approach but does not evaluate specific screening tools or intervention efficacy.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background: Hypertensive disorders in pregnancy remain a major cause of maternal and perinatal morbidity and mortality, especially when gestational hypertension progresses to pre-eclampsia, eclampsia, stroke, organ dysfunction, fetal growth restriction, or preterm birth. Objective: This review aimed to synthesize recent determinants of hypertensive disorders in pregnancy and organize them into domains that can support antenatal risk screening. Methods: This systematic literature review followed PRISMA 2020 guidance. Searches were conducted in June 2026 through PubMed (n=386), Scopus (n=284), ScienceDirect (n=216), Google Scholar (n=220), and official public-health sources (n=8). The review used a PEO framework: pregnant women, exposure to socio-demographic, clinical-metabolic, pregnancy-placental, behavioral-environmental, or health-system determinants, and occurrence of hypertensive disorders of pregnancy. Articles published mainly from 2022 to 2026 were prioritized; key official documents were retained for epidemiological and guideline context. Quality appraisal used JBI checklists for observational studies, AMSTAR 2 for systematic reviews, and AACODS for official reports. Results: From 1,114 records, 26 sources met eligibility criteria. The most consistent determinants were chronic hypertension, previous pre-eclampsia, high body mass index or obesity, diabetes, kidney disease, nulliparity, advanced maternal age, multiple gestation, and delayed or limited antenatal risk identification. Conclusion: Hypertensive disorders in pregnancy are multifactorial and require integrated antenatal screening that combines biomedical history, obstetric risk, nutrition, environmental context, and access to care.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.